PTEN and hepatocellular carcinoma: The cellular proliferation in HCC is driven by various genetic and epigenetic alterations that promote the abnormal growth of liver cells, including the activation of oncogenes such as MYC and RAS, and the inactivation of tumor suppressor genes such as TP53 and PTEN [1].